CONSULTING AGREEMENTConsulting Services Agreement |
|
|
You are currently viewing: This Consulting Services Agreement involves
Avalon Pharmaceuticals, Inc | Company Scientific Advisory Board. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here. |
|
|
|
Search Consulting Services Agreement by:
Exhibit 10.12B
Amendment to
CONSULTING AGREEMENT
By and Between
Avalon Pharmaceuticals, Inc. and Michael Kurman Consulting
The parties hereby agree this 24th day of November , 2004 to amend the Consulting Agreement By and Between Avalon Pharmaceuticals, Inc. (“Company” or “the Company”) and Michael Kurman Consulting (“Consultant” or “the Consultant”) as set forth herein.
For purposes of this amendment, the “Consulting Agreement” shall refer to the Consulting Agreement between the parties dated August 3, 2004 (including, without limitation, all Exhibits to that Consulting Agreement).
The “Amendment” shall refer to this “Amendment to Consulting Agreement By and Between Avalon Pharmaceuticals, Inc. and Michael Kurman Consulting.”
1) Services as a Member of Company Scientific Advisory Board.
In addition to the consulting services set forth in Section 2.1 and Exhibit A of the Consulting Agreement, Consultant agrees to serve as a member of Company’s Scientific Advisory Board throughout the effective period of this Amendment (including, without limitation, any renewals). Consultant further agrees to allow the Company to use Consultant’s name in scientific, marketing and financing activities.
2) Compensation.
In addition to the compensation set forth in Section 3 of the Consulting Agreement, the Company hereby agrees to provide to Consultant the compensation set forth below in this Section 2 in consideration for Consultant’s services as a member of Company’s Scientific Advisory Board. Consultant agrees that the compensation provided for in this Section 2 constitutes Consultant’s full and exclusive consideration and compensation for all services to be performed by Consultant in his capacity as a member of Company’s Scientific Advisory Board.
Company will pay Consultant the following for his services on Company’s Scientific Advisory Board:
| (a) a $2,500 fee for each meeting of the Scientific Advisory Board which the Consultant attends in person, at Company’s offices or at such other location as Company may reasonably designate; and | ||||
| (b) 4,000 non-qualified stock options annually, for each year in which Consultant serves as a member of Company’s Scientific Advisory Board, at the market price as determined by the Board of Directors as of the time the President and CEO decides that the Consultant has met the requirements of Section 1 above. | ||||
